Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Horse study offers new insights on human disease
AHT scientists were working on Streptococcus equi, which causes strangles in horses.
Scientists ID genes linked with Streptococcus pyogenes

Research in horses has managed to identify new genes that are associated with Streptococcus pyogenes, an important cause of human disease.

Streptococcus pyogenes are responsible for 600 million cases of pharyngitis in humans every year, and infections caused by the bug have seen a dramatic rise around the world over the past 20 years.

The bacteria is also to blame for a further 100 million cases of invasive disease, such as scarlet fever, acute rheumatic fever and necrotising fasciitis.

Despite the cost to human health, the Animal Health Trust (AHT) said little is known about which of the 1,800 genes are required for it to infect people and persist in the throat.

AHT scientists were working on Streptococcus equi, which causes strangles in horses and is closely related to Streptococcus pyogenes. They developed a new technique that allows the importance of every gene in the bug to be tested at once, rather than one at a time.

The technique was transferred to the lab at Houston Methodist Research Institute, where it was also proved effective in the study of Streptococcus pyogenes. The team were able to identify 92 genes that were required for the bacteria to grow in human saliva.

Dr James Musser, a professor at the institute, said this has the potential to accelerate research into this important human pathogen.

In follow-on tests, the team were able to immediately confirm that six of these new genes did affect growth in human saliva, meaning there is potential for novel therapeutics and vaccines.

Dr Andrew Waller, head of bacteriology at AHT, added: “We are delighted that a technique developed at the AHT to learn more about Streptococcus equi and strangles in horses has provided new results that could benefit people too.

“We have learnt a huge amount about our bug through following the work being done on human diseases, and it is great to be able to give something back in return. This study highlights the similarities of animal and human pathogens.

“We hope that our technique will also prove useful for the study and prevention of other diseases, regardless of the animal they affect.”

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.